Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CELU
#3620
Celularity Inc. Class A Common Stock
1.2
1
0.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
0.00%
Monatliche Änderung
-4.72%
6 month change
-69.67%
Jahresänderung
-3.20%
Vorheriger Schlusskurs
1.2
1
Open
1.2
1
Bid
Ask
Low
1.2
1
High
1.2
1
Volumen
3
Märkte
Aktien
Gesundheitswesen
CELU
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
2.88 M
13.77 M
16.5 M
21.98 M
22.55 M
99.32 M
Valuation ratios
Enterprise value
—
—
—
—
49.08 M
204.93 M
Price to earnings ratio
—
—
—
—
-0.79
-2.74
Price to sales ratio
—
—
—
—
0.84
3.77
Price to cash flow ratio
—
—
—
—
7.11
42.3
Price to book ratio
—
—
—
—
5.15
7.42
Enterprise value to EBITDA ratio
—
—
—
—
-1.58
-5.33
Profitability ratios
Return on assets %
0.01
0.24
0.04
1.36
0.44
0.66
Return on equity %
0.53
1.01
0.07
4.79
6.55
7.2
Return on invested capital %
5.34
133.77
26.65
266.54
104.97
155.54
Gross margin %
100
54.76
9.4
29.66
72.36
163.13
Operating margin %
-308.66
511.17
142.42
844.44
70.75
663.66
EBITDA margin %
—
-1 367.35
-1 495.69
-1 580.95
-57.33
-589.45
Net margin %
-192.39
469.27
78.95
862.04
106.77
1 110.46
Liquidity ratios
Quick ratio
—
1.89
0.45
0.21
0.28
0.86
Current ratio
0.11
2.25
0.54
0.29
0.38
1.17
Inventory turnover
—
16.72
19.41
15.82
6.87
6.7
Asset turnover
-0
0.06
0.04
0.08
0.39
0.32
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
9.2
2.17
0.29
0.25
EBIT per share
—
—
-18.57
-20.73
-1.78
-2.12
EBITDA per share
—
—
-17.94
-20.21
-1.42
-1.81
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
0.93
0.01
0.03
0.09
Net current asset value per share
—
—
2.24
1.11
0.94
3
Tangible book value per share
—
—
-2.79
1.27
-0.35
-0.23
Working capital per share
—
—
-1.91
-2.67
-1.51
-7.31
Book value per share
—
—
13.28
2.3
0.4
2.46
Nachrichten
Verkauf von Verlustvorträgen: Celularity sichert sich Liquidität von 12,2 Millionen US-Dollar
Celularity receives $12.2 million from sale of tax credits
CMS-Entscheidung zu Hautersatzprodukten belastet Celularity-Aktie
Celularity stock drops after CMS withdraws skin substitute LCDs
Medicare nimmt geplante Einschränkungen bei der Kostenerstattung für Hautersatzprodukte zurück
Medicare withdraws skin substitute coverage changes set for 2026
Celularity erhält 10-Millionen-Dollar-Finanzierung von DoubleLine-Mitgründer/n
Celularity secures $10 million financing from DoubleLine co-founder
Celularity sichert sich Finanzierung von bis zu 12 Millionen US-Dollar
Celularity secures up to $12 million in financing for longevity focus
Studie von Celularity: Zelltherapie zeigt Potenzial bei diabetischem Fußgeschwür
Celularity’s diabetic foot ulcer therapy shows promise in clinical trial